These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 28164626)

  • 1. Expression of CD200R1 and its Ligand CD200 on T-helper Lymphocytes of Pediatric Patients with Ulcerative Colitis and Crohn's Disease.
    Elshal MF; Aldahlawi AM; Saadah OI; Mccoy JP
    Clin Lab; 2016 Aug; 62(8):1521-1529. PubMed ID: 28164626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Dendritic Cells Expressing CD200R1 in Children with Inflammatory Bowel Disease: Correlation with Th17 and Regulatory T Cells.
    Elshal MF; Aldahlawi AM; Saadah OI; McCoy JP
    Int J Mol Sci; 2015 Dec; 16(12):28998-9010. PubMed ID: 26690123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CD200/CD200R Signaling Pathway in Regulation of CD4+T Cell Subsets During Thermal Ablation of Hepatocellular Carcinoma.
    Huang S; Pan Y; Zhang Q; Sun W
    Med Sci Monit; 2019 Mar; 25():1718-1728. PubMed ID: 30838977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crossover Subsets of CD4
    Li J; Ueno A; Iacucci M; Fort Gasia M; Jijon HB; Panaccione R; Kaplan GG; Beck PL; Luider J; Barkema HW; Qian J; Gui X; Ghosh S
    Dig Dis Sci; 2017 Sep; 62(9):2357-2368. PubMed ID: 28573508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
    Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
    Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased CD200R expression on monocyte-derived macrophages correlates with Th17/Treg imbalance and disease activity in rheumatoid arthritis patients.
    Gao S; Hao B; Yang XF; Chen WQ
    Inflamm Res; 2014 Jun; 63(6):441-50. PubMed ID: 24496593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.
    Ueno A; Jijon H; Chan R; Ford K; Hirota C; Kaplan GG; Beck PL; Iacucci M; Fort Gasia M; Barkema HW; Panaccione R; Ghosh S
    Inflamm Bowel Dis; 2013 Nov; 19(12):2522-34. PubMed ID: 24097227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant CD200/CD200R1 expression and its potential role in Th17 cell differentiation, chemotaxis and osteoclastogenesis in rheumatoid arthritis.
    Ren Y; Yang B; Yin Y; Leng X; Jiang Y; Zhang L; Li Y; Li X; Zhang F; He W; Zhang X; Cao X
    Rheumatology (Oxford); 2015 Apr; 54(4):712-21. PubMed ID: 25261692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
    Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
    Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant CD200/CD200R1 expression and function in systemic lupus erythematosus contributes to abnormal T-cell responsiveness and dendritic cell activity.
    Li Y; Zhao LD; Tong LS; Qian SN; Ren Y; Zhang L; Ding X; Chen Y; Wang YX; Zhang W; Zeng XF; Zhang FC; Tang FL; Zhang X; Ba DN; He W; Cao XT; Lipsky PE
    Arthritis Res Ther; 2012 May; 14(3):R123. PubMed ID: 22621248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased CD4
    Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ
    World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological Features of Inflammatory Bowel Disease are Associated With Different CD4+ T Cell Subsets in Colonic Mucosal Lamina Propria.
    Gui X; Li J; Ueno A; Iacucci M; Qian J; Ghosh S
    J Crohns Colitis; 2018 Nov; 12(12):1448-1458. PubMed ID: 30137280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases.
    Hovhannisyan Z; Treatman J; Littman DR; Mayer L
    Gastroenterology; 2011 Mar; 140(3):957-65. PubMed ID: 21147109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. αEβ7 Integrin Identifies Subsets of Pro-Inflammatory Colonic CD4+ T Lymphocytes in Ulcerative Colitis.
    Lamb CA; Mansfield JC; Tew GW; Gibbons D; Long AK; Irving P; Diehl L; Eastham-Anderson J; Price MB; O'Boyle G; Jones DEJ; O'Byrne S; Hayday A; Keir ME; Egen JG; Kirby JA
    J Crohns Colitis; 2017 May; 11(5):610-620. PubMed ID: 28453768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
    Cook L; Stahl M; Han X; Nazli A; MacDonald KN; Wong MQ; Tsai K; Dizzell S; Jacobson K; Bressler B; Kaushic C; Vallance BA; Steiner TS; Levings MK
    Gastroenterology; 2019 Dec; 157(6):1584-1598. PubMed ID: 31513797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
    Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
    J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.
    Globig AM; Hennecke N; Martin B; Seidl M; Ruf G; Hasselblatt P; Thimme R; Bengsch B
    Inflamm Bowel Dis; 2014 Dec; 20(12):2321-9. PubMed ID: 25248005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
    Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
    Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymocyte/splenocyte-derived CD4+CD25+Treg stimulated by anti-CD200R2 derived dendritic cells suppress mixed leukocyte cultures and skin graft rejection.
    Gorczynski RM
    Transplantation; 2006 Apr; 81(7):1027-34. PubMed ID: 16612280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation between Treg quantification assays in inflammatory bowel disease patients.
    Brandhorst G; Petrova DT; Weigand S; Eberle C; von Ahsen N; Schmitz J; Schultze FC; Raddatz D; Karaus M; Oellerich M; Walson PD
    World J Gastroenterol; 2015 Mar; 21(11):3325-9. PubMed ID: 25805940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.